Orbimed Advisors LLC Natera, Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 687,500 shares of NTRA stock, worth $107 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares

687,500

Previous 687,500 -0.0%

Holding current value

$107 Million

Previous $74.4 Million 17.37%

% of portfolio

2.06%

Previous 1.79%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$85.28 - $112.6 $18.1 Million - $23.9 Million	-211,931 Reduced 23.56%	687,500 $74.4 Million
Q1 2024 May 15, 2024	SELL	$59.21 - $92.9 $3.26 Million - $5.11 Million	-55,050 Reduced 5.77%	899,431 $82.3 Million
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $1.27 Million - $2.12 Million	33,900 Added 3.68%	954,481 $59.8 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $2.3 Million - $3.31 Million	-53,000 Reduced 5.44%	920,581 $40.7 Million
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $35.6 Million - $56.7 Million	-972,772 Reduced 49.98%	973,581 $54.1 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $15.1 Million - $21.1 Million	441,200 Added 29.31%	1,946,353 $78.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.93 - $56.68 $5.77 Million - $8.85 Million	-156,200 Reduced 9.4%	1,505,153 $66 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $1.86 Million - $2.94 Million	65,968 Added 4.13%	1,661,353 $58.9 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $5.5 Million - $16.6 Million	181,400 Added 12.83%	1,595,385 $64.9 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $13.7 Million - $18.9 Million	-158,815 Reduced 10.1%	1,413,985 $132 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $48.6 Million - $61.3 Million	-485,000 Reduced 23.57%	1,572,800 $175 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $11.9 Million - $16.5 Million	-138,100 Reduced 6.29%	2,057,800 $234 Million
Q1 2021 May 17, 2021	BUY	$91.47 - $124.36 $7.79 Million - $10.6 Million	85,200 Added 4.04%	2,195,900 $223 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $51.8 Million - $82.1 Million	-1,129,814 Reduced 34.87%	2,110,700 $152 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $2.81 Million - $5.31 Million	-106,486 Reduced 3.18%	3,240,514 $162 Million
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $15.7 Million - $36.4 Million	906,387 Added 37.14%	3,347,000 $99.9 Million
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $18 Million - $22.6 Million	-559,515 Reduced 18.65%	2,440,613 $82.2 Million
Q3 2019 Nov 14, 2019	SELL	$25.38 - $34.89 $5.69 Million - $7.82 Million	-224,200 Reduced 6.95%	3,000,128 $98.4 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $38.1 Million - $59.2 Million	2,146,742 Added 199.22%	3,224,328 $88.9 Million
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $4.46 Million - $8.11 Million	393,500 Added 57.52%	1,077,586 $22.2 Million
Q3 2018 Nov 14, 2018	SELL	$18.82 - $28.96 $5.65 Million - $8.69 Million	-300,000 Reduced 30.49%	684,086 $16.4 Million
Q2 2018 Aug 14, 2018	SELL	$8.79 - $19.98 $5.2 Million - $11.8 Million	-592,104 Reduced 37.57%	984,086 $18.5 Million
Q3 2017 Nov 14, 2017	BUY	$8.02 - $13.33 $12.6 Million - $21 Million	1,576,190	1,576,190 $20.3 Million

Others Institutions Holding NTRA

# of Institutions

528

Shares Held

119M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Natera, Inc. Transaction History